| Due Diligence for Asset Managers |
|---|
|
You have viewed 8 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Zentalis Pharmaceuticals Inc | |
|---|---|
| Ticker | ZNTL |
| CIK # | 0001725160 |
| CUSIP | 98943L107 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 530 Seventh Avenue, Suite 2201, New York, NY 10018 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| ZENO Pharma LLC | 2019-09-05 | Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Commission: $3,625,555 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001725160] | 10-K | |
| [0001725160] | 10-Q | |
| [0001725160] | 3 | |
| [0001725160] | 4 | |
| [0001725160] | 8-K | |
| [0001725160] | D | |
| [0001725160] | SC 13D | |
| [0001725160] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vultaggio Vincent
Common Stock
|
2026-02-10 | Sell | 6,894 | $2.42 | 16,683 |
|
Bruns Ingmar
Common Stock
|
2026-02-09 | Sell | 335 | $2.39 | 801 |
|
Eastland Julia Marie
Common Stock
|
2026-02-09 | Sell | 889 | $2.39 | 2,125 |
|
Vultaggio Vincent
Common Stock
|
2026-02-09 | Sell | 3,379 | $2.39 | 8,076 |
|
Eastland Julia Marie
Common Stock
|
2026-02-06 | Sell | 7,866 | $2.43 | 19,114 |
|
Bruns Ingmar
Common Stock
|
2026-02-06 | Sell | 2,962 | $2.43 | 7,198 |
|
Vultaggio Vincent
Common Stock
|
2026-02-06 | Sell | 29,951 | $2.43 | 72,781 |
|
Vultaggio Vincent
Common Stock
|
2026-02-03 | Sell | 556 | $2.52 | 1,401 |
|
Vultaggio Vincent
Common Stock
|
2026-02-02 | Sell | 2,540 | $2.55 | 6,477 |
|
Bruns Ingmar
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 365,000 | $0.00 | |
|
Bucher James B
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 100,000 | $0.00 | |
|
Vultaggio Vincent
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 100,000 | $0.00 | |
|
Eastland Julia Marie
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 775,000 | $0.00 | |
|
Walters Group +2
Common Stock
|
2025-12-31 | Buy | 6,459,973 | $1.20 | 7,751,968 |
|
Matrix Capital Management Company LP +1
Common Stock, par value $0.001 per share
|
2025-12-15 | Sell | 7,500,000 | $1.33 | 9,975,000 |
|
Bucher James B
Stock Option (Right to Buy) · derivative
|
2025-10-01 | Grant | 400,000 | $0.00 | |
|
Skvarka Jan
Common Stock
|
2025-06-17 | Grant | 57,603 | $0.00 | |
|
Kariuki Enoch
Common Stock
|
2025-06-17 | Grant | 57,603 | $0.00 | |
|
Myers Scott Dunseth
Common Stock
|
2025-06-17 | Grant | 57,603 | $0.00 | |
|
Walker Luke Nathaniel
Common Stock
|
2025-06-17 | Grant | 57,603 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 102 | 41,184,981 |
| 2025-12-31 | 86 | 37,823,285 |
| 2025-09-30 | 99 | 51,164,556 |
| 2025-06-30 | 117 | 52,769,753 |
| 2025-03-31 | 133 | 55,807,434 |
| 2024-12-31 | 142 | 63,293,544 |
| 2024-09-30 | 136 | 71,528,950 |
| 2024-06-30 | 145 | 75,920,394 |
| 2024-03-31 | 142 | 80,655,420 |
| 2023-12-31 | 121 | 77,614,370 |
| 2023-09-30 | 137 | 75,797,997 |
| 2023-06-30 | 135 | 77,953,416 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 0 | 68,816 |
| Marquette Asset Management LLC | [2026-06-30] | SOLE | 0 | 28,973 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 209 | 209 | Prev | Page 1 | Next |